238 related articles for article (PubMed ID: 28109136)
1. Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress.
Bahrami A; Amerizadeh F; ShahidSales S; Khazaei M; Ghayour-Mobarhan M; Sadeghnia HR; Maftouh M; Hassanian SM; Avan A
J Cell Biochem; 2017 Aug; 118(8):1979-1983. PubMed ID: 28109136
[TBL] [Abstract][Full Text] [Related]
2. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
[TBL] [Abstract][Full Text] [Related]
3. Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer?
Prossomariti A; Piazzi G; Alquati C; Ricciardiello L
Cell Mol Gastroenterol Hepatol; 2020; 10(3):491-506. PubMed ID: 32334125
[TBL] [Abstract][Full Text] [Related]
4. Wnt signalling is a bi-directional vulnerability of cancer cells.
Duffy DJ; Krstic A; Schwarzl T; Halasz M; Iljin K; Fey D; Haley B; Whilde J; Haapa-Paananen S; Fey V; Fischer M; Westermann F; Henrich KO; Bannert S; Higgins DG; Kolch W
Oncotarget; 2016 Sep; 7(37):60310-60331. PubMed ID: 27531891
[TBL] [Abstract][Full Text] [Related]
5. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
[TBL] [Abstract][Full Text] [Related]
6. Wnt signaling as a therapeutic target for cancer.
Herbst A; Kolligs FT
Methods Mol Biol; 2007; 361():63-91. PubMed ID: 17172707
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells.
Leow PC; Tian Q; Ong ZY; Yang Z; Ee PL
Invest New Drugs; 2010 Dec; 28(6):766-82. PubMed ID: 19730790
[TBL] [Abstract][Full Text] [Related]
8. Wnt signaling in osteosarcoma.
Lin CH; Ji T; Chen CF; Hoang BH
Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer.
Cheng X; Xu X; Chen D; Zhao F; Wang W
Biomed Pharmacother; 2019 Feb; 110():473-481. PubMed ID: 30530050
[TBL] [Abstract][Full Text] [Related]
10. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
Lee SC; Kim OH; Lee SK; Kim SJ
Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
[TBL] [Abstract][Full Text] [Related]
11. All Trans-Retinoic Acid Mediates MED28/HMG Box-Containing Protein 1 (HBP1)/β-Catenin Signaling in Human Colorectal Cancer Cells.
Lee MF; Hsieh NT; Huang CY; Li CI
J Cell Physiol; 2016 Aug; 231(8):1796-803. PubMed ID: 26660958
[TBL] [Abstract][Full Text] [Related]
12. Wnt9A Induction Linked to Suppression of Human Colorectal Cancer Cell Proliferation.
Ali I; Medegan B; Braun DP
Int J Mol Sci; 2016 Apr; 17(4):495. PubMed ID: 27049382
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ß-catenin signaling.
He BC; Gao JL; Luo X; Luo J; Shen J; Wang L; Zhou Q; Wang YT; Luu HH; Haydon RC; Wang CZ; Du W; Yuan CS; He TC; Zhang BQ
Int J Oncol; 2011 Feb; 38(2):437-45. PubMed ID: 21152855
[TBL] [Abstract][Full Text] [Related]
14. Flavonoids and Wnt/β-catenin signaling: potential role in colorectal cancer therapies.
Amado NG; Predes D; Moreno MM; Carvalho IO; Mendes FA; Abreu JG
Int J Mol Sci; 2014 Jul; 15(7):12094-106. PubMed ID: 25007066
[TBL] [Abstract][Full Text] [Related]
15. On target? Strategies and progress in the development of therapies for colorectal cancer targeted against WNT signalling.
McDonald SL; Silver AR
Colorectal Dis; 2011 Apr; 13(4):360-9. PubMed ID: 20015264
[TBL] [Abstract][Full Text] [Related]
16. Determinants of Wnt/β-catenin pathway dependency in colorectal cancer.
Scholer-Dahirel A; McLaughlin ME
Cell Cycle; 2012 Jan; 11(1):9-10. PubMed ID: 22157091
[No Abstract] [Full Text] [Related]
17. The inhibition of Wnt/β-catenin signaling pathway in human colon cancer cells by sulindac.
Tai WP; Hu PJ; Wu J; Lin XC
Tumori; 2014; 100(1):97-101. PubMed ID: 24675499
[TBL] [Abstract][Full Text] [Related]
18. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.
Arqués O; Chicote I; Puig I; Tenbaum SP; Argilés G; Dienstmann R; Fernández N; Caratù G; Matito J; Silberschmidt D; Rodon J; Landolfi S; Prat A; Espín E; Charco R; Nuciforo P; Vivancos A; Shao W; Tabernero J; Palmer HG
Clin Cancer Res; 2016 Feb; 22(3):644-56. PubMed ID: 26224873
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of anti-Wnt/β-catenin signaling agents by pGL4-TOP transfected stable cells with a luciferase reporter system.
Chuang KA; Lieu CH; Tsai WJ; Wu MH; Chen YC; Liao JF; Wang CC; Kuo YC
Braz J Med Biol Res; 2010 Oct; 43(10):931-41. PubMed ID: 20835687
[TBL] [Abstract][Full Text] [Related]
20. Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells.
Thacker PC; Karunagaran D
PLoS One; 2015; 10(3):e0120045. PubMed ID: 25786122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]